Cargando…

GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer

Neoadjuvant chemoradiotherapy (nCRT) combined with surgery is a standard therapy for locally advanced rectal cancer (LARC). The aim of this study was to assess the expression of GOLPH3 (Golgi phosphoprotein 3), a newly found oncogene, in LARC as well as its relationship with nCRT sensitivity and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Kunli, Zhao, Qianqian, Yue, Jinbo, Shi, Pengyue, Yan, Hongjiang, Xu, Xiaoqing, Wang, Renben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356558/ https://www.ncbi.nlm.nih.gov/pubmed/27634904 http://dx.doi.org/10.18632/oncotarget.12008

Ejemplares similares

Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: Association with response to neoadjuvant therapy and prognosis
por: Meng, Xiangjiao, et al.
Publicado: (2014)

The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Meng, Xiangjiao, et al.
Publicado: (2014)

Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinoma
por: Zhao, Qianqian, et al.
Publicado: (2016)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer
por: Li, Huan, et al.
Publicado: (2012)

Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis
por: Zhao, Qianqian, et al.
Publicado: (2016)

High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis
por: Wang, Jian-Hua, et al.
Publicado: (2012)

GOLPH3 and YB-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer
por: El-Maqsoud, Nehad M. R. Abd, et al.
Publicado: (2015)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
por: Ho, Vincent, et al.
Publicado: (2018)

Perineural and lymphovascular invasion predicts for poor prognosis in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery
por: Sun, Quanquan, et al.
Publicado: (2019)

PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis
por: Chou, Chia-Lin, et al.
Publicado: (2020)

GOLPH3: a novel biomarker that correlates with poor survival and resistance to chemotherapy in breast cancer
por: Tang, Shicong, et al.
Publicado: (2017)

GOLPH3L antagonizes GOLPH3 to determine Golgi morphology
por: Ng, Michelle M., et al.
Publicado: (2013)

Prognostic value of serum γ-glutamyl transferase in unresectable hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization combined with conformal radiotherapy
por: CHEN, DONG, et al.
Publicado: (2014)

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
por: Xue, Y, et al.
Publicado: (2014)

Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer
por: Liu, Chao, et al.
Publicado: (2022)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Yaqi, et al.
Publicado: (2019)

The Role of GOLPH3L in the Prognosis and NACT response in Cervical Cancer
por: Feng, Yanling, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma
por: Zhang, Tong, et al.
Publicado: (2021)

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
por: Chen, Tzu-Ju, et al.
Publicado: (2022)

Consolidation chemotherapy may improve pathological complete response for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a retrospective study
por: Cui, Jin, et al.
Publicado: (2020)

A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma
por: Chen, Dong, et al.
Publicado: (2014)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
por: Liu, Jing, et al.
Publicado: (2017)

Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy
por: Sun, Yi, et al.
Publicado: (2023)

Total neoadjuvant treatment in locally advanced rectal cancer
por: De Felice, Francesca, et al.
Publicado: (2021)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

GOLPH3 and GOLPH3L are broad-spectrum COPI adaptors for sorting into intra-Golgi transport vesicles
por: Welch, Lawrence G., et al.
Publicado: (2021)

Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy
por: Guan, Bingjie, et al.
Publicado: (2023)

Pathological complete response in MMR-deficient/MSI-high and KRAS-mutant patient with locally advanced rectal cancer after neoadjuvant chemoradiation with immunotherapy: A case report
por: Zhang, Mai, et al.
Publicado: (2022)

Overexpression of leptin receptor in human glioblastoma: Correlation with vasculogenic mimicry and poor prognosis
por: Han, Guosheng, et al.
Publicado: (2017)

Expression of GOLPH3 protein in colon cancer tissues and its association with the prognosis of patients
por: Zhou, Bo, et al.
Publicado: (2016)

GPR116 overexpression correlates with poor prognosis in gastric cancer
por: Zheng, Tian, et al.
Publicado: (2021)

The overexpression of GPX8 is correlated with poor prognosis in GBM patients
por: Li, Sibo, et al.
Publicado: (2022)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Overexpression of SKA3 correlates with poor prognosis in female early breast cancer
por: Zhong, Yue, et al.
Publicado: (2021)

Superiority of helical tomotherapy on liver sparing and dose escalation in hepatocellular carcinoma: a comparison study of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy
por: Zhao, Qianqian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_imh71050otul3ln10peujdpt90